As of 2025-07-15, the Relative Valuation of Allogene Therapeutics Inc (ALLO) is (16.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.29 USD, the upside of Allogene Therapeutics Inc based on Relative Valuation is -1387.7%.
The range of the Relative Valuation is (16.43) - (22.52) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 19.5x | 14.6x |
| Forward P/E multiples | 13.6x - 21.6x | 14.2x |
| Fair Price | (16.43) - (22.52) | (16.61) |
| Upside | -1373.4% - -1845.6% | -1387.7% |
| Date | P/E |
| 2025-07-11 | -1.11 |
| 2025-07-10 | -1.09 |
| 2025-07-09 | -1.05 |
| 2025-07-08 | -1.04 |
| 2025-07-07 | -1.01 |
| 2025-07-03 | -1.03 |
| 2025-07-02 | -1.04 |
| 2025-07-01 | -1.02 |
| 2025-06-30 | -0.98 |
| 2025-06-27 | -1.02 |
| 2025-06-26 | -1.04 |
| 2025-06-25 | -1.07 |
| 2025-06-24 | -1.08 |
| 2025-06-23 | -1.06 |
| 2025-06-20 | -1.07 |
| 2025-06-18 | -1.12 |
| 2025-06-17 | -1.13 |
| 2025-06-16 | -1.19 |
| 2025-06-13 | -1.16 |
| 2025-06-12 | -1.21 |
| 2025-06-11 | -1.26 |
| 2025-06-10 | -1.27 |
| 2025-06-09 | -1.22 |
| 2025-06-06 | -1.23 |
| 2025-06-05 | -1.12 |
| 2025-06-04 | -1.12 |
| 2025-06-03 | -1.17 |
| 2025-06-02 | -1.10 |
| 2025-05-30 | -1.01 |
| 2025-05-29 | -1.02 |
| 2025-05-28 | -0.99 |
| 2025-05-27 | -0.94 |
| 2025-05-23 | -0.92 |
| 2025-05-22 | -0.94 |
| 2025-05-21 | -0.96 |
| 2025-05-20 | -1.01 |
| 2025-05-19 | -0.94 |
| 2025-05-16 | -0.96 |
| 2025-05-15 | -0.94 |
| 2025-05-14 | -0.83 |
| 2025-05-13 | -0.98 |
| 2025-05-12 | -1.01 |
| 2025-05-09 | -1.01 |
| 2025-05-08 | -1.02 |
| 2025-05-07 | -1.04 |
| 2025-05-06 | -1.11 |
| 2025-05-05 | -1.40 |
| 2025-05-02 | -1.47 |
| 2025-05-01 | -1.47 |
| 2025-04-30 | -1.46 |